Speaker illustration

Doctor Masaki Shimizu

Sapporo Medical University, Sapporo (Japan)

Rapamycin ameliorates doxorubicin-induced cardiomyopathy through suppression of RIPK1-independent necroptosis

Event: ESC Congress 2023

Topic: Drugs, Drug Targets

Session: Molecular cardio-oncology


Nuclear accumulation of MLKL induces necroptosis in cardiomyocytes: potential implication in Doxorubicin-induced cardiotoxicity.

Event: ESC Congress 2022

Topic: Drugs, Drug Targets

Session: Acquired forms of heart failure: cancer and inflammatory disorders


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb